Please wait while the formulary information is being retrieved.
HUMIRA(CF) PEN CROHN'S-UC-HS (adalimumab)
- Crohn's disease
- Moderate to severe plaque psoriasis
- Non-infectious uveitis affecting the posterior segment
- Hidradenitis suppurativa
- Ulcerative colitis
Humira(CF) Pen Crohn's-Ulc Colitis-Hid Sup Strt 80 mg/0.8 mL subcut kt
- Inject by subcutaneous route in the abdomen or thigh (rotate sites) per package directions
Crohn's disease
- Inject 0.8 milliliter (80 mg) by subcutaneous route once in the abdomen or thigh
- Inject 0.8 milliliter (80 mg) by subcutaneous route once daily in theabdomen or thigh (rotate sites) for 2 consecutive days
- Inject 0.8 milliliter (80 mg) by subcutaneous route in the abdomen orthigh (rotate sites) on days 1 and 2 then inject 0.8 ml (80 mg) on day 15
- Inject 1.6 milliliters (160 mg) by subcutaneous route in the abdomen or thigh (rotate sites) on day 1 then inject 0.8 ml (80 mg) on day 15
- Inject 1.6 milliliters (160 mg) by subcutaneous route once in the abdomen or thigh
- Inject by subcutaneous route in the abdomen or thigh (rotate sites) per package directions
Hidradenitis suppurativa
- Inject 0.8 milliliter (80 mg) by subcutaneous route once in the abdomen or thigh
- Inject 0.8 milliliter (80 mg) by subcutaneous route once daily in theabdomen or thigh (rotate sites) for 2 consecutive days
- Inject 0.8 milliliter (80 mg) by subcutaneous route in the abdomen orthigh (rotate sites) on days 1 and 2 then inject 0.8 ml (80 mg) on day 15
- Inject 1.6 milliliters (160 mg) by subcutaneous route in the abdomen or thigh (rotate sites) on day 1 then inject 0.8 ml (80 mg) on day 15
- Inject 1.6 milliliters (160 mg) by subcutaneous route once in the abdomen or thigh
- Inject by subcutaneous route in the abdomen or thigh (rotate sites) per package directions
Ulcerative colitis
- Inject 0.8 milliliter (80 mg) by subcutaneous route once in the abdomen or thigh
- Inject 0.8 milliliter (80 mg) by subcutaneous route once daily in theabdomen or thigh (rotate sites) for 2 consecutive days
- Inject 0.8 milliliter (80 mg) by subcutaneous route in the abdomen orthigh (rotate sites) on days 1 and 2 then inject 0.8 ml (80 mg) on day 15
- Inject 1.6 milliliters (160 mg) by subcutaneous route in the abdomen or thigh (rotate sites) on day 1 then inject 0.8 ml (80 mg) on day 15
- Inject 1.6 milliliters (160 mg) by subcutaneous route once in the abdomen or thigh
- Inject by subcutaneous route in the abdomen or thigh (rotate sites) per package directions
- abatacept (with maltose)
- adenovirus vac live type-4 & 7
- adenovirus vaccine live type-4
- adenovirus vaccine live type-7
- BCG vaccine, live (PF)
- flu vac,qval 2013-14 (2-49yrs)
- Flumist 2013-2014
- M-m-r Ii (pf)
- measles,mumps&rubella vacc(PF)
- measles,mumps,rub,varicel(PF)
- natalizumab
- Orencia (with Maltose)
- Proquad (pf)
- Rotateq Vaccine
- rotavirus vaccine live, penta
- tofacitinib
- typhoid vaccine
- Tysabri
- varicella virus vacc live (PF)
- Varivax (pf)
- Vivotif Berna Vaccine
- Xeljanz
- yellow fever vaccine live (PF)
- Yf-vax (pf)
- Zostavax (pf)
- zoster vaccine live (PF)
Contraindicated
- Actemra
- anakinra
- Arcalyst
- Azasan
- azathioprine
- azathioprine sodium
- canakinumab (PF)
- clozapine
- Clozaril
- deferiprone
- Fazaclo
- Ferriprox
- Ilaris (pf)
- Imuran
- Kineret
- mercaptopurine
- Purinethol
- rilonacept
- tocilizumab
- Versacloz
Severe
Moderate
- None
- Active tuberculosis
- Extrapulmonary pneumocystosis
- Lupus-like syndrome
- Miliary tuberculosis
- Opportunistic fungal infection
- Pneumocystis jirovecii pneumonia
- Reactivated tuberculosis
- Reactivation of hepatitis B
- Sepsis
Contraindicated
- Basal cell carcinoma of skin
- Chronic heart failure
- Chronic hepatitis B
- Chronic infection
- Demyelination
- Guillain-barre syndrome
- Hepatitis B immune due to latent hepatitis B infection
- Hepatosplenic t-cell lymphoma
- Inactive tuberculosis
- Leukemia
- Malignancy
- Malignant lymphoma
- Multiple sclerosis
- Neutropenic disorder
- Opportunistic viral infection
- Pancytopenia
- Severe infection
- Squamous cell carcinoma
- Thrombocytopenic disorder
- Viral hepatitis B
Severe
Moderate
- None
HUMIRA(CF) PEN CROHN'S-UC-HS (adalimumab)
- Crohn's disease
- Moderate to severe plaque psoriasis
- Non-infectious uveitis affecting the posterior segment
- Hidradenitis suppurativa
- Ulcerative colitis
- Bacterial sepsis
- Cellulitis
- Dehydration
- Fever
- Infection
- Lupus-like syndrome
- Skin rash
- Upper respiratory infection
- Erythema
- Headache disorder
- Injection site sequelae
- Nausea
- Pharyngitis
- Pruritus of skin
- Sinusitis
More Frequent
Severe
Less Severe
- Abnormal hepatic function tests
- Acute myocardial infarction
- Agranulocytosis
- Asthma
- Atrial fibrillation
- Biliary calculus
- Bronchospastic pulmonary disease
- Cardiac arrest
- Cardiac arrhythmia
- Cataracts
- Chest pain
- Chronic heart failure
- Cystitis
- Dyspnea
- Erysipelas
- Erythrocytosis
- Flu-like symptoms
- Fracture
- Fungal infection
- Gastrointestinal hemorrhage
- Hepatic necrosis
- Herpes zoster
- Hypertension
- Hypertensive crisis
- Ketosis
- Kidney stone
- Leg vein thrombosis
- Leukopenia
- Malignant lymphoma
- Monoclonal gammopathy
- Multiple sclerosis
- Palpitations
- Pericardial effusion
- Pericarditis
- Peripheral edema
- Pneumonia
- Pseudohypoparathyroidism
- Pyelonephritis
- Reactivated tuberculosis
- Secondary polycythemia
- Subdural intracranial hemorrhage
- Syncope
- Tachycardia
- Urinary tract infection
- Acute abdominal pain
- Acute confusion
- Arthritis
- Back pain
- Bone disease
- Cramps
- Esophagitis
- Gastroenteritis
- Hematuria
- Hypercholesterolemia
- Hyperlipidemia
- Impaired wound healing
- Irregular menstrual periods
- Limb pain
- Muscle weakness
- Paresthesia
- Pelvic pain
- Pleural effusions
- Septic arthritis
- Synovitis
- Tremor
- Vomiting
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Active tuberculosis
- Anaphylaxis
- Angioedema
- Aplastic anemia
- Appendicitis
- Autoimmune hepatitis
- Basal cell carcinoma of skin
- Blastomycosis
- Cerebrovascular accident
- Cholecystitis
- Coccidioidomycosis
- Cutaneous vasculitis
- Deep venous thrombosis
- Demyelination
- Diverticulitis of gastrointestinal tract
- Drug-exacerbated psoriasis
- Erythema multiforme
- Guillain-barre syndrome
- Heart failure
- Hepatic failure
- Hepatitis
- Hepatosplenic t-cell lymphoma
- Histoplasmosis
- Intestinal perforation
- Legionnaires' disease
- Leukemia
- Listeriosis
- Malignancy
- Malignant melanoma
- Merkel cell carcinoma
- Opportunistic fungal infection
- Optic neuritis
- Pancreatitis
- Pancytopenia
- Protozoal infection
- Pulmonary fibrosis
- Pulmonary thromboembolism
- Reactivation of hepatitis B
- Sarcoidosis
- Squamous cell carcinoma
- Stevens-johnson syndrome
- Thrombocytopenic disorder
- Vasculitis
- Worsening of chronic heart failure
Less Severe
- Alopecia
- Granuloma annulare
Contraindicated
None
Severe Precaution
Adalimumab
Not studied age <2 years. Possible malignancy, lymphoma risk. Risk of neutropenia, streptococcal pharyngitis, appendicitis, herpes zoster and simplex, myositis, and metrorrhagia.
- 1 Day – 2 Years
- Not studied age <2 years. Possible malignancy, lymphoma risk. Risk of neutropenia, streptococcal pharyngitis, appendicitis, herpes zoster and simplex, myositis, and metrorrhagia.
Management or Monitoring Precaution
Adalimumab
Higher incidence of infection in pediatrics. Monitor for lymphoma, malignancy, leukemia, appendicitis and rare report of hepatosplenic T-cell lymphoma.
- 2 Years – 18 Years
- Higher incidence of infection in pediatrics. Monitor for lymphoma, malignancy, leukemia, appendicitis and rare report of hepatosplenic T-cell lymphoma.
Adalimumab
- Severity Level:
2
- Additional Notes: Crosses placenta;human and animal data have shown no known embryo/fetal toxicity
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
Adalimumab
Limited data suggest low levels excreted; infant absorption unlikely
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Excreted | Not known; no or inclusive data | Limited data suggest low levels excreted; infant absorption unlikely |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
Adalimumab
General-Patients older than 65 years of age are at increased risk for severe infection and malignancy.
| Organ / System | HEP | REN | CARD | ENDO | NEURO / PSYCH | PULM |
| Increased Risk / Adverse Effects | N | N | N | N | N | N |
BEERS: N HEDIS: N STOPP: N
No Known Risk
None
- This medication can decrease your body's ability to fight an infection. This effect can lead to very serious (possibly fatal) infections (such as fungal infections, bacterial infections including tuberculosis). Tell your doctor your medical history, especially of past/recent/current infections.<br /><br />You should also tell your doctor if you have lived or traveled in areas where certain fungal infections (such as coccidioidomycosis, histoplasmosis) are common or if you have been near someone with tuberculosis. Areas where these types of fungal infections are commonly found include the Ohio and Mississippi River valleys and the southwestern United States. Tell your doctor right away if you develop signs of infection (see Side Effects section).<br /><br /> Your doctor will test you for tuberculosis (TB) infection before and during treatment with this drug. If you are diagnosed with TB, your doctor will first prescribe treatment for this to prevent a serious TB infection while using adalimumab. Though it is very unlikely to happen, there is a risk (especially in children/teens/young adults) of developing cancer (such as lymphoma, skin cancer) due to this medication or due to your medical condition.<br /><br />Discuss the risks and benefits of treatment with your doctor. Tell your doctor right away if you develop symptoms such as a fever that doesn't go away, unusual lumps/growths, swollen glands, unexplained weight loss, or night sweats.
| Crohn's disease | |
| K50 | Crohn's disease [regional enteritis] |
| K50.0 | Crohn's disease of small intestine |
| K50.00 | Crohn's disease of small intestine without complications |
| K50.01 | Crohn's disease of small intestine with complications |
| K50.011 | Crohn's disease of small intestine with rectal bleeding |
| K50.012 | Crohn's disease of small intestine with intestinal obstruction |
| K50.013 | Crohn's disease of small intestine with fistula |
| K50.014 | Crohn's disease of small intestine with abscess |
| K50.018 | Crohn's disease of small intestine with other complication |
| K50.019 | Crohn's disease of small intestine with unspecified complications |
| K50.1 | Crohn's disease of large intestine |
| K50.10 | Crohn's disease of large intestine without complications |
| K50.11 | Crohn's disease of large intestine with complications |
| K50.111 | Crohn's disease of large intestine with rectal bleeding |
| K50.112 | Crohn's disease of large intestine with intestinal obstruction |
| K50.113 | Crohn's disease of large intestine with fistula |
| K50.114 | Crohn's disease of large intestine with abscess |
| K50.118 | Crohn's disease of large intestine with other complication |
| K50.119 | Crohn's disease of large intestine with unspecified complications |
| K50.8 | Crohn's disease of both small and large intestine |
| K50.80 | Crohn's disease of both small and large intestine without complications |
| K50.81 | Crohn's disease of both small and large intestine with complications |
| K50.811 | Crohn's disease of both small and large intestine with rectal bleeding |
| K50.812 | Crohn's disease of both small and large intestine with intestinal obstruction |
| K50.813 | Crohn's disease of both small and large intestine with fistula |
| K50.814 | Crohn's disease of both small and large intestine with abscess |
| K50.818 | Crohn's disease of both small and large intestine with other complication |
| K50.819 | Crohn's disease of both small and large intestine with unspecified complications |
| K50.9 | Crohn's disease, unspecified |
| K50.90 | Crohn's disease, unspecified, without complications |
| K50.91 | Crohn's disease, unspecified, with complications |
| K50.911 | Crohn's disease, unspecified, with rectal bleeding |
| K50.912 | Crohn's disease, unspecified, with intestinal obstruction |
| K50.913 | Crohn's disease, unspecified, with fistula |
| K50.914 | Crohn's disease, unspecified, with abscess |
| K50.918 | Crohn's disease, unspecified, with other complication |
| K50.919 | Crohn's disease, unspecified, with unspecified complications |
| Hidradenitis suppurativa | |
| L73.2 | Hidradenitis suppurativa |
| Moderate to severe plaque psoriasis | |
| L40.0 | Psoriasis vulgaris |
| L40.9 | Psoriasis, unspecified |
| Non-infectious uveitis affecting the posterior segment | |
| H20.82 | Vogt-koyanagi syndrome |
| H20.821 | Vogt-koyanagi syndrome, right eye |
| H20.822 | Vogt-koyanagi syndrome, left eye |
| H20.823 | Vogt-koyanagi syndrome, bilateral |
| H20.829 | Vogt-koyanagi syndrome, unspecified eye |
| H30.14 | Acute posterior multifocal placoid pigment epitheliopathy |
| H30.141 | Acute posterior multifocal placoid pigment epitheliopathy, right eye |
| H30.142 | Acute posterior multifocal placoid pigment epitheliopathy, left eye |
| H30.143 | Acute posterior multifocal placoid pigment epitheliopathy, bilateral |
| H30.149 | Acute posterior multifocal placoid pigment epitheliopathy, unspecified eye |
| H30.81 | Harada's disease |
| H30.811 | Harada's disease, right eye |
| H30.812 | Harada's disease, left eye |
| H30.813 | Harada's disease, bilateral |
| H30.819 | Harada's disease, unspecified eye |
| H44.13 | Sympathetic uveitis |
| H44.131 | Sympathetic uveitis, right eye |
| H44.132 | Sympathetic uveitis, left eye |
| H44.133 | Sympathetic uveitis, bilateral |
| H44.139 | Sympathetic uveitis, unspecified eye |
| Ulcerative colitis | |
| K51 | Ulcerative colitis |
| K51.0 | Ulcerative (chronic) pancolitis |
| K51.00 | Ulcerative (chronic) pancolitis without complications |
| K51.01 | Ulcerative (chronic) pancolitis with complications |
| K51.011 | Ulcerative (chronic) pancolitis with rectal bleeding |
| K51.012 | Ulcerative (chronic) pancolitis with intestinal obstruction |
| K51.013 | Ulcerative (chronic) pancolitis with fistula |
| K51.014 | Ulcerative (chronic) pancolitis with abscess |
| K51.018 | Ulcerative (chronic) pancolitis with other complication |
| K51.019 | Ulcerative (chronic) pancolitis with unspecified complications |
| K51.2 | Ulcerative (chronic) proctitis |
| K51.20 | Ulcerative (chronic) proctitis without complications |
| K51.21 | Ulcerative (chronic) proctitis with complications |
| K51.211 | Ulcerative (chronic) proctitis with rectal bleeding |
| K51.212 | Ulcerative (chronic) proctitis with intestinal obstruction |
| K51.213 | Ulcerative (chronic) proctitis with fistula |
| K51.214 | Ulcerative (chronic) proctitis with abscess |
| K51.218 | Ulcerative (chronic) proctitis with other complication |
| K51.219 | Ulcerative (chronic) proctitis with unspecified complications |
| K51.3 | Ulcerative (chronic) rectosigmoiditis |
| K51.30 | Ulcerative (chronic) rectosigmoiditis without complications |
| K51.31 | Ulcerative (chronic) rectosigmoiditis with complications |
| K51.311 | Ulcerative (chronic) rectosigmoiditis with rectal bleeding |
| K51.312 | Ulcerative (chronic) rectosigmoiditis with intestinal obstruction |
| K51.313 | Ulcerative (chronic) rectosigmoiditis with fistula |
| K51.314 | Ulcerative (chronic) rectosigmoiditis with abscess |
| K51.318 | Ulcerative (chronic) rectosigmoiditis with other complication |
| K51.319 | Ulcerative (chronic) rectosigmoiditis with unspecified complications |
| K51.5 | Left sided colitis |
| K51.50 | Left sided colitis without complications |
| K51.51 | Left sided colitis with complications |
| K51.511 | Left sided colitis with rectal bleeding |
| K51.512 | Left sided colitis with intestinal obstruction |
| K51.513 | Left sided colitis with fistula |
| K51.514 | Left sided colitis with abscess |
| K51.518 | Left sided colitis with other complication |
| K51.519 | Left sided colitis with unspecified complications |
| K51.8 | Other ulcerative colitis |
| K51.80 | Other ulcerative colitis without complications |
| K51.81 | Other ulcerative colitis with complications |
| K51.811 | Other ulcerative colitis with rectal bleeding |
| K51.812 | Other ulcerative colitis with intestinal obstruction |
| K51.813 | Other ulcerative colitis with fistula |
| K51.814 | Other ulcerative colitis with abscess |
| K51.818 | Other ulcerative colitis with other complication |
| K51.819 | Other ulcerative colitis with unspecified complications |
| K51.9 | Ulcerative colitis, unspecified |
| K51.90 | Ulcerative colitis, unspecified, without complications |
| K51.91 | Ulcerative colitis, unspecified, with complications |
| K51.911 | Ulcerative colitis, unspecified with rectal bleeding |
| K51.912 | Ulcerative colitis, unspecified with intestinal obstruction |
| K51.913 | Ulcerative colitis, unspecified with fistula |
| K51.914 | Ulcerative colitis, unspecified with abscess |
| K51.918 | Ulcerative colitis, unspecified with other complication |
| K51.919 | Ulcerative colitis, unspecified with unspecified complications |
| 0-9 | A-Z |
|---|---|
| H20.82 | Vogt-koyanagi syndrome |
| H20.821 | Vogt-koyanagi syndrome, right eye |
| H20.822 | Vogt-koyanagi syndrome, left eye |
| H20.823 | Vogt-koyanagi syndrome, bilateral |
| H20.829 | Vogt-koyanagi syndrome, unspecified eye |
| H30.14 | Acute posterior multifocal placoid pigment epitheliopathy |
| H30.141 | Acute posterior multifocal placoid pigment epitheliopathy, right eye |
| H30.142 | Acute posterior multifocal placoid pigment epitheliopathy, left eye |
| H30.143 | Acute posterior multifocal placoid pigment epitheliopathy, bilateral |
| H30.149 | Acute posterior multifocal placoid pigment epitheliopathy, unspecified eye |
| H30.81 | Harada's disease |
| H30.811 | Harada's disease, right eye |
| H30.812 | Harada's disease, left eye |
| H30.813 | Harada's disease, bilateral |
| H30.819 | Harada's disease, unspecified eye |
| H44.13 | Sympathetic uveitis |
| H44.131 | Sympathetic uveitis, right eye |
| H44.132 | Sympathetic uveitis, left eye |
| H44.133 | Sympathetic uveitis, bilateral |
| H44.139 | Sympathetic uveitis, unspecified eye |
| K50 | Crohn's disease [regional enteritis] |
| K50.0 | Crohn's disease of small intestine |
| K50.00 | Crohn's disease of small intestine without complications |
| K50.01 | Crohn's disease of small intestine with complications |
| K50.011 | Crohn's disease of small intestine with rectal bleeding |
| K50.012 | Crohn's disease of small intestine with intestinal obstruction |
| K50.013 | Crohn's disease of small intestine with fistula |
| K50.014 | Crohn's disease of small intestine with abscess |
| K50.018 | Crohn's disease of small intestine with other complication |
| K50.019 | Crohn's disease of small intestine with unspecified complications |
| K50.1 | Crohn's disease of large intestine |
| K50.10 | Crohn's disease of large intestine without complications |
| K50.11 | Crohn's disease of large intestine with complications |
| K50.111 | Crohn's disease of large intestine with rectal bleeding |
| K50.112 | Crohn's disease of large intestine with intestinal obstruction |
| K50.113 | Crohn's disease of large intestine with fistula |
| K50.114 | Crohn's disease of large intestine with abscess |
| K50.118 | Crohn's disease of large intestine with other complication |
| K50.119 | Crohn's disease of large intestine with unspecified complications |
| K50.8 | Crohn's disease of both small and large intestine |
| K50.80 | Crohn's disease of both small and large intestine without complications |
| K50.81 | Crohn's disease of both small and large intestine with complications |
| K50.811 | Crohn's disease of both small and large intestine with rectal bleeding |
| K50.812 | Crohn's disease of both small and large intestine with intestinal obstruction |
| K50.813 | Crohn's disease of both small and large intestine with fistula |
| K50.814 | Crohn's disease of both small and large intestine with abscess |
| K50.818 | Crohn's disease of both small and large intestine with other complication |
| K50.819 | Crohn's disease of both small and large intestine with unspecified complications |
| K50.9 | Crohn's disease, unspecified |
| K50.90 | Crohn's disease, unspecified, without complications |
| K50.91 | Crohn's disease, unspecified, with complications |
| K50.911 | Crohn's disease, unspecified, with rectal bleeding |
| K50.912 | Crohn's disease, unspecified, with intestinal obstruction |
| K50.913 | Crohn's disease, unspecified, with fistula |
| K50.914 | Crohn's disease, unspecified, with abscess |
| K50.918 | Crohn's disease, unspecified, with other complication |
| K50.919 | Crohn's disease, unspecified, with unspecified complications |
| K51 | Ulcerative colitis |
| K51.0 | Ulcerative (chronic) pancolitis |
| K51.00 | Ulcerative (chronic) pancolitis without complications |
| K51.01 | Ulcerative (chronic) pancolitis with complications |
| K51.011 | Ulcerative (chronic) pancolitis with rectal bleeding |
| K51.012 | Ulcerative (chronic) pancolitis with intestinal obstruction |
| K51.013 | Ulcerative (chronic) pancolitis with fistula |
| K51.014 | Ulcerative (chronic) pancolitis with abscess |
| K51.018 | Ulcerative (chronic) pancolitis with other complication |
| K51.019 | Ulcerative (chronic) pancolitis with unspecified complications |
| K51.2 | Ulcerative (chronic) proctitis |
| K51.20 | Ulcerative (chronic) proctitis without complications |
| K51.21 | Ulcerative (chronic) proctitis with complications |
| K51.211 | Ulcerative (chronic) proctitis with rectal bleeding |
| K51.212 | Ulcerative (chronic) proctitis with intestinal obstruction |
| K51.213 | Ulcerative (chronic) proctitis with fistula |
| K51.214 | Ulcerative (chronic) proctitis with abscess |
| K51.218 | Ulcerative (chronic) proctitis with other complication |
| K51.219 | Ulcerative (chronic) proctitis with unspecified complications |
| K51.3 | Ulcerative (chronic) rectosigmoiditis |
| K51.30 | Ulcerative (chronic) rectosigmoiditis without complications |
| K51.31 | Ulcerative (chronic) rectosigmoiditis with complications |
| K51.311 | Ulcerative (chronic) rectosigmoiditis with rectal bleeding |
| K51.312 | Ulcerative (chronic) rectosigmoiditis with intestinal obstruction |
| K51.313 | Ulcerative (chronic) rectosigmoiditis with fistula |
| K51.314 | Ulcerative (chronic) rectosigmoiditis with abscess |
| K51.318 | Ulcerative (chronic) rectosigmoiditis with other complication |
| K51.319 | Ulcerative (chronic) rectosigmoiditis with unspecified complications |
| K51.5 | Left sided colitis |
| K51.50 | Left sided colitis without complications |
| K51.51 | Left sided colitis with complications |
| K51.511 | Left sided colitis with rectal bleeding |
| K51.512 | Left sided colitis with intestinal obstruction |
| K51.513 | Left sided colitis with fistula |
| K51.514 | Left sided colitis with abscess |
| K51.518 | Left sided colitis with other complication |
| K51.519 | Left sided colitis with unspecified complications |
| K51.8 | Other ulcerative colitis |
| K51.80 | Other ulcerative colitis without complications |
| K51.81 | Other ulcerative colitis with complications |
| K51.811 | Other ulcerative colitis with rectal bleeding |
| K51.812 | Other ulcerative colitis with intestinal obstruction |
| K51.813 | Other ulcerative colitis with fistula |
| K51.814 | Other ulcerative colitis with abscess |
| K51.818 | Other ulcerative colitis with other complication |
| K51.819 | Other ulcerative colitis with unspecified complications |
| K51.9 | Ulcerative colitis, unspecified |
| K51.90 | Ulcerative colitis, unspecified, without complications |
| K51.91 | Ulcerative colitis, unspecified, with complications |
| K51.911 | Ulcerative colitis, unspecified with rectal bleeding |
| K51.912 | Ulcerative colitis, unspecified with intestinal obstruction |
| K51.913 | Ulcerative colitis, unspecified with fistula |
| K51.914 | Ulcerative colitis, unspecified with abscess |
| K51.918 | Ulcerative colitis, unspecified with other complication |
| K51.919 | Ulcerative colitis, unspecified with unspecified complications |
| L40.0 | Psoriasis vulgaris |
| L40.9 | Psoriasis, unspecified |
| L73.2 | Hidradenitis suppurativa |
Formulary Reference Tool